SARSCoV‐2 infection and COVID‐19 outcomes in rheumatic diseases: a systematic literature review and meta‐analysis

…, COVID‐19 Global Rheumatology Alliance - … & Rheumatology, 2022 - Wiley Online Library
… with rheumatic diseases were reported and SARSCoV-2 … data regarding patients with
rheumatic diseases, did not … data regarding outcomes related to SARSCoV-2 infection or its …

[HTML][HTML] The correlation between SARS-CoV-2 infection and rheumatic disease

Z Gao, X Wang, F Lin, K Dong - Autoimmunity reviews, 2020 - ncbi.nlm.nih.gov
… with rheumatic disease who … of rheumatic disease patients infected by SARS-CoV-2 might
not reflect the real susceptibility of patients. However, the potential susceptibility of SARS-CoV-…

Anti-rheumatic in SARS Cov 2: benefit or risk?

F Ferrara, C Pelliccia, A Vitiello - Authorea Preprints, 2020 - authorea.com
… are affected by rheumatic diseases and over 5 and a half million men and women affected
by rheumatological diseases are present in Italy. These are chronic diseases and therefore …

SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: a cross-sectional study on 916 patients

M Zen, E Fuzzi, D Astorri, F Saccon, R Padoan… - Journal of …, 2020 - Elsevier
… Whether patients with autoimmune rheumatic diseases (ARD) have a higher risk for
SARS-CoV-2 infection (COVID-19) and how SARS-CoV-2 pandemic impacts on adherence to …

Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment

S Shah, D Danda, C Kavadichanda, S Das… - Rheumatology …, 2020 - Springer
… of COVID-19 mimicking rheumatic musculoskeletal diseases (RMDs) are being reported. …
coronavirus-2 (SARS-CoV-2) infection can potentially lead to an array of rheumatological and …

SARS-CoV-2 infection among patients with systemic autoimmune diseases

G Emmi, A Bettiol, I Mattioli, E Silvestri, G Di Scala… - Autoimmunity …, 2020 - Elsevier
… of SARS-CoV-2 cases with rheumatic diseases [15,16], our experience shows that patients
with chronic systemic autoimmune diseases do not seem to be at increased risk of SARS-CoV

Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform …

FPB Kroon, A Najm, A Alunno, JW Schoones… - … rheumatic diseases, 2022 - ard.bmj.com
Objectives Perform a systematic literature review (SLR) on risk and prognosis of SARS-CoV-2
infection and vaccination against SARS-CoV-2 in patients with rheumatic and …

Basic immunology may lead to translational therapeutic rationale: SARSCoV‐2 and rheumatic diseases

E Gremese, ES Ferraccioli, S Alivernini… - European Journal of …, 2020 - Wiley Online Library
… The outbreak of COVID-19 (SARS-CoVrheumatic diseases, who believe to be at higher
risk of developing the threatening acute respiratory distress syndrome that lead some SARS-CoV

High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study

J Loarce-Martos, A García-Fernández… - Rheumatology …, 2020 - Springer
… outcomes of rheumatic and musculoskeletal disease (RMD) … acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) … Rheumatology Department of our hospital were screened for …

A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine

HM Moutsopoulos - Journal of Autoimmunity, 2021 - Elsevier
… the pandemic induced by SARS-CoV-2. However, there is limited data available on the
effectiveness and safety of these vaccines in autoimmune rheumatic disease (ARD) patients …